Essential COVID-19 & HIV Resources

Email Updates

Place quotation marks around exact phrases (e.g. "new york"). Note: Trial names have a space before the number (e.g. HVTN 100).

You are here

Home

Trial Search

Trial Name Prevention Option Phase Start Date Sponsors Countries Population Candidate(s) Status
CONRAD B17-144 Microbicides, Multipurpose Prevention Technologies II December 2018 Kenya Women TFV/LNG ring, TFV ring Ongoing
CONRAD A15-140 Microbicides, PrEP I April 2016 United States of America Women TFV ring, TDF/FTC (Truvada) Completed
CONRAD A15-138 Microbicides, Multipurpose Prevention Technologies I September 2017 United States of America, Dominican Republic Men Levonorgestrel, tenofovir Completed
Population Council #728 Microbicides I October 2017 United States of America Women PC-6500 Completed
Population Council #558 Microbicides, Multipurpose Prevention Technologies I May 2014 United States of America Women PC-1005 gel, HEC gel Completed
OB-002H Microbicides I Poland MSM, Women Planned
HPX3002/HVTN 706: Mosaico HIV Vaccine III June 2019 Janssen Vaccines & Prevention B.V. United States of America, Argentina, Italy, Mexico, Peru, Poland, Spain Men Ad26.Mos4.HIV, gp140 Ongoing
CONRAD A18-146 Microbicides, Multipurpose Prevention Technologies I December 2018 CONRAD United States of America Women Elvitegravir (EVG), F/TAF Completed
Implementation of the Pre-Exposure Prophylaxis (PrEP) to HIV in Brazilian transgender women (PrEParadas) PrEP Demo Project July 2018 Brazilian Ministry of Health Brazil Ongoing
DuoGel Microbicides I November 2017 United States of America Women, Men IQP-0528 Ongoing
MTN-041 Microbicides, PrEP Other May 2018 Malawi, South Africa, Uganda, Zimbabwe Women Dapivirine Ring, TDF/FTC (Truvada) Ongoing
MTN-043 Microbicides Open Label Malawi, South Africa, Uganda, Zimbabwe Women Dapivirine Ring Planned
MTN-044/IPM 053 Microbicides, Multipurpose Prevention Technologies Open Label, I June 2018 United States of America Women Dapivirine-Levonorgestrel ring Ongoing
HVTN 125 HIV Vaccine Ib July 2018 DAIDS United States of America Withdrawn
HVTN 127/HPTN 087 Antibody Related Research I February 2018 DAIDS United States of America Women, Men VRC07-523LS Ongoing
PrEPVacc HIV Vaccine, PrEP IIb January 2020 Sponsor: Imperial College London. Coordinating partners: P Kaleebu, E Ruzagira (MRC/UVRI & LSHTM, Uganda); J Weber/J Fox/C Kingsley (Imperial College, UK); S McCormack (UCL, UK); K Chinyenze (IAVI-Kenya); G Pantaleo/S Ding (CHUV/EVF, Switzerland) Uganda, South Africa, United Republic of Tanzania, Mozambique DNA , MVA, Protein, TAF/FTC (Descovy), TDF/FTC (Truvada) Planned
Study to Evaluate the Safety of Griffithsin in a Carrageenan Gel in Healthy Women Microbicides I October 2017 United States of America Women GRFT Completed
DREAM-01 Microbicides, Multipurpose Prevention Technologies I October 2016 United States of America, Malawi Men Ongoing
CONRAD 137 PrEP I October 2016 Women F/TAF, TDF/FTC (Truvada) Completed
HVTN 124 HIV Vaccine I February 2018 DAIDS United States of America Women, Men gp120 (A,B,C,A/E)/GLA-SE, env (A,B,C,A/E)/gag (C)/GLA-SE Ongoing

Pages

CSVDoc